Longitudinal Alterations of Retinal and Choroidal Structure in Patients Recovered from COVID-19

Objective. To evaluate the midterm longitudinal changes in chorioretinal structures in patients with coronavirus disease 2019 (COVID-19). Methods. Thirty-four eyes of 17 COVID-19 patients were enrolled. The patients underwent retinal and choroidal imaging upon the recovery (baseline) after 1 and 3 m...

Full description

Saved in:
Bibliographic Details
Main Authors: Mojtaba Abrishami, Kiana Hassanpour, Ghodsieh Zamani, Seyedeh Maryam Hosseini, Nasser Shoeibi, Zahra Emamverdian, Amir Zamani, Nasibeh Amini, Majid Abrishami
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2022/4123328
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564915959758848
author Mojtaba Abrishami
Kiana Hassanpour
Ghodsieh Zamani
Seyedeh Maryam Hosseini
Nasser Shoeibi
Zahra Emamverdian
Amir Zamani
Nasibeh Amini
Majid Abrishami
author_facet Mojtaba Abrishami
Kiana Hassanpour
Ghodsieh Zamani
Seyedeh Maryam Hosseini
Nasser Shoeibi
Zahra Emamverdian
Amir Zamani
Nasibeh Amini
Majid Abrishami
author_sort Mojtaba Abrishami
collection DOAJ
description Objective. To evaluate the midterm longitudinal changes in chorioretinal structures in patients with coronavirus disease 2019 (COVID-19). Methods. Thirty-four eyes of 17 COVID-19 patients were enrolled. The patients underwent retinal and choroidal imaging upon the recovery (baseline) after 1 and 3 months. Retinal measurements in fovea, parafovea, and perifovea were recorded. To calculate choroidal vascularity index (CVI), luminal and total choroidal areas were measured using Sonada's method. Choroidal thickness was measured at the subfovea 500 microns temporal and nasal to the fovea. Results. Mean CVI was 0.64 ± 0.04 at baseline that significantly increased to 0.67 ± 0.05 (P = 0.012) after 1 month and again significantly decreased to 0.63 ± 0.05 after 3 months (P < 0.001). While the stromal component showed a significant decrease between the baseline and first-month values (1.16 ± 0.29 to 1.01 ± 0.27, P = 0.03), the luminal area mostly changed between months 1 and 3 (2.03 ± 0.28 to 1.91 ± 0.23, P = 0.045). The average of subfoveal choroidal thickness and retinal thickness remained unchanged. Conclusion. CVI is increased in patients with COVID-19 1 month after recovery from COVID-19 and returns to baseline values after 3 months. Regarding the reversible nature of changes, there might be a prominent role in inflammation.
format Article
id doaj-art-d025342ea2d941ada4264a0a0a5b71f5
institution Kabale University
issn 2090-0058
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-d025342ea2d941ada4264a0a0a5b71f52025-02-03T01:09:59ZengWileyJournal of Ophthalmology2090-00582022-01-01202210.1155/2022/4123328Longitudinal Alterations of Retinal and Choroidal Structure in Patients Recovered from COVID-19Mojtaba Abrishami0Kiana Hassanpour1Ghodsieh Zamani2Seyedeh Maryam Hosseini3Nasser Shoeibi4Zahra Emamverdian5Amir Zamani6Nasibeh Amini7Majid Abrishami8Eye Research CenterOphthalmic Research CenterEye Research CenterEye Research CenterEye Research CenterEye Research CenterDepartment of General SurgeryEye Research CenterEye Research CenterObjective. To evaluate the midterm longitudinal changes in chorioretinal structures in patients with coronavirus disease 2019 (COVID-19). Methods. Thirty-four eyes of 17 COVID-19 patients were enrolled. The patients underwent retinal and choroidal imaging upon the recovery (baseline) after 1 and 3 months. Retinal measurements in fovea, parafovea, and perifovea were recorded. To calculate choroidal vascularity index (CVI), luminal and total choroidal areas were measured using Sonada's method. Choroidal thickness was measured at the subfovea 500 microns temporal and nasal to the fovea. Results. Mean CVI was 0.64 ± 0.04 at baseline that significantly increased to 0.67 ± 0.05 (P = 0.012) after 1 month and again significantly decreased to 0.63 ± 0.05 after 3 months (P < 0.001). While the stromal component showed a significant decrease between the baseline and first-month values (1.16 ± 0.29 to 1.01 ± 0.27, P = 0.03), the luminal area mostly changed between months 1 and 3 (2.03 ± 0.28 to 1.91 ± 0.23, P = 0.045). The average of subfoveal choroidal thickness and retinal thickness remained unchanged. Conclusion. CVI is increased in patients with COVID-19 1 month after recovery from COVID-19 and returns to baseline values after 3 months. Regarding the reversible nature of changes, there might be a prominent role in inflammation.http://dx.doi.org/10.1155/2022/4123328
spellingShingle Mojtaba Abrishami
Kiana Hassanpour
Ghodsieh Zamani
Seyedeh Maryam Hosseini
Nasser Shoeibi
Zahra Emamverdian
Amir Zamani
Nasibeh Amini
Majid Abrishami
Longitudinal Alterations of Retinal and Choroidal Structure in Patients Recovered from COVID-19
Journal of Ophthalmology
title Longitudinal Alterations of Retinal and Choroidal Structure in Patients Recovered from COVID-19
title_full Longitudinal Alterations of Retinal and Choroidal Structure in Patients Recovered from COVID-19
title_fullStr Longitudinal Alterations of Retinal and Choroidal Structure in Patients Recovered from COVID-19
title_full_unstemmed Longitudinal Alterations of Retinal and Choroidal Structure in Patients Recovered from COVID-19
title_short Longitudinal Alterations of Retinal and Choroidal Structure in Patients Recovered from COVID-19
title_sort longitudinal alterations of retinal and choroidal structure in patients recovered from covid 19
url http://dx.doi.org/10.1155/2022/4123328
work_keys_str_mv AT mojtabaabrishami longitudinalalterationsofretinalandchoroidalstructureinpatientsrecoveredfromcovid19
AT kianahassanpour longitudinalalterationsofretinalandchoroidalstructureinpatientsrecoveredfromcovid19
AT ghodsiehzamani longitudinalalterationsofretinalandchoroidalstructureinpatientsrecoveredfromcovid19
AT seyedehmaryamhosseini longitudinalalterationsofretinalandchoroidalstructureinpatientsrecoveredfromcovid19
AT nassershoeibi longitudinalalterationsofretinalandchoroidalstructureinpatientsrecoveredfromcovid19
AT zahraemamverdian longitudinalalterationsofretinalandchoroidalstructureinpatientsrecoveredfromcovid19
AT amirzamani longitudinalalterationsofretinalandchoroidalstructureinpatientsrecoveredfromcovid19
AT nasibehamini longitudinalalterationsofretinalandchoroidalstructureinpatientsrecoveredfromcovid19
AT majidabrishami longitudinalalterationsofretinalandchoroidalstructureinpatientsrecoveredfromcovid19